Synopsys Posts Financial Results for Third Quarter Fiscal Year 2016
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P on track for muted open as Middle East tensions weigh; AI stocks boost Nasdaq
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Oil rises on Iran war stalemate; near-term potential for further gains seen limited
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Piper Sandler Starts SoFi Technologies (SOFI) at Overweight
- Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
Needham & Company Raises Price Target on Synopsys (SNPS) to $60 Following 3Q
August 18, 2016 8:18 AM EDTNeedham & Company reiterated a Buy rating on Synopsys (NASDAQ: SNPS), and raised the price target to $60.00 (from $54.00), following the company's 3Q earnings report. SNPS reported revenue of $615.2MM and NG EPS of $0.76, exceeding the consensus of $603.1MM and $0.75, respectively.
Analyst Richard Valera... More
Synopsys (SNPS) Tops Q3 EPS by 2c
August 17, 2016 4:11 PM EDTSynopsys (NASDAQ: SNPS) reported Q3 EPS of $0.76, $0.02 better than the analyst estimate of $0.74. Revenue for the quarter came in at $615.2 million versus the consensus estimate of $602.89 million.
GUIDANCE:
Synopsys sees Q4 2016 EPS of $0.75-$0.78, versus the consensus of $0.75. Synopsys sees Q4... More
